Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program
Who's in front heading 'round the bend?
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
Many funds' fortunes have turned amid these stocks' volatility.
Plus, Vanguard says 401(k) investors stayed the course in 2008, Macquarie Group buys Delaware Investments, more leveraged ETF warnings, and more.
The broad stock runup in the first half of 2013 was a boon to ClearBridge Aggressive Growth, and comanager Evan Bauman says that the fund is well-positioned for the market going forward.